Listen to this podcast for a concise summary of the latest clinical practice guidelines for identifying glycemic targets and managing T2DM in various patient populations including, older adults, individuals with increased cardiac or renal risk, and those at risk for hypoglycemic events.
Lifestyle management has proven effective for addressing modifiable health risks, but can be challenging for patients to implement and maintain. This session will focus on wellness coaching as an important component of healthy living, both for patients and providers. Participants will learn about the benefits of engaging patients in health and wellness coaching, and will discuss strategies for incorporating this practice into their own patient care setting(s).
This podcast will provide an update on the medical literature and practice guidelines pertaining to exercise. Participants will deepen their understanding of the physical and mental health benefits of exercise and will examine the evidence for a variety of common approaches to exercise (cardiovascular, strength training, high intensity interval training). Barriers to participation in exercise regimens – both for patients and providers – will be explored.
Patient Scenarios: A 62-Year-Old Man with Recurrent COPD Exacerbations (An Interactive Case Experience)
Your patient is ready for you! In this interactive activity, you will be guided through the case of a patient with COPD via a series of questions and complementary videos. Questions will test your strengths and weaknesses around COPD management, with some questions and feedback tailored directly to your management choices. After each question, you will be presented with learning moments designed to help increase your confidence managing patients with COPD and reducing risk of COPD exacerbations. Please note that any data, indications, and guidelines presented in this activity are current as of 10/1/2020 and they are subject to change as new information is published.
This podcast will provide an update on autism spectrum disorder (ASD) including surveillance and screening, clinical signs, evaluation, diagnosis, and management.
Bacterial vaginosis—especially recurrent BV—can be an ordeal for patients and their healthcare providers. Listen as Dr. Martin Quan provides concise and up-to-date information on the pathophysiology, diagnosis, and management of BV.
Guest: Paul E. Sax, MDMusic Credit: Richard Onorato
So much has changed concerning COVID-19 management, but few interventions are clearly beneficial in the outpatient management of patients. This podcast will try to answer some of the common questions community based providers have about handling their patients’ illness.
This podcast will review the harms of tobacco products and discuss the growing popularity and dangers of non-cigarette tobacco products. Faculty will discuss the vaping associated lung injury and outline approaches that PCPs can use to help their patients with tobacco cessation.
This podcast provides a succinct overview of what you need to know to manage osteoporosis confidently, including selecting candidates for treatment, monitoring patients, and the benefits and potential adverse effects of osteoporosis pharmacotherapy.
This podcast will review updates to the clinical guidelines for the management of chronic obstructive pulmonary disease, tailored specifically to primary care. The discussion will include the diagnosis and basic management of COPD, when to consider escalating and deescalating treatment regimens, and when to consider expert referral.
In this podcast, Dr. Richard Pratley will answer Pri-Med learner questions submitted during recent CME sessions focusing on glucagon like peptide-1 receptor agonists (GLP-1 RAs). Join us for expert answers to questions about who can benefit from GLP-1 RAs, the safety of these medications in different populations, and much more. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/10/2020 and they are subject to change as new information is published.
Join cardiologist Ty Gluckman, MD in part two of this two-part podcast series as he reviews the unmet needs of patients with heart failure with reduced ejection fraction (HFrEF) and discusses the evidence on emerging pharmacologic treatments for HFrEF. He will describe the current data in HFrEF for the following drug classes: SGLT2 inhibitors, soluble guanylate cyclase stimulators, and selective cardiac myosin activators.